Biotech Values

[ocyanblue]

after they messed up a reported
p-value it may be worth doing.

When did they mess up reporting some p-value and what on?

If they could show
the cd54 upreg in placebo patients and show
that the survival benefit only survives when you
actually reinfuse the upregged cells, then I
would be proven wrong but I haven't seen that yet.

Unless I am missing something, the above statement is a bit weird. Placebos were reinfused with their own blood untouched per trial protocol. But if you change "placebo" to "treated" in your statement, didn't the announced top-line result say what you want? Ie, the higher the upreg rate, the better the survival chance.